Ronacaleret

DRUG2 trials

Sponsors

GlaxoSmithKline

Conditions

Osteoporosis

Phase 1

To Estimate Relative Bioavailability of 5 Formulations of Ronacaleret Given to Healthy Postmenopausal Females

CompletedNCT00651534

GlaxoSmithKlineOsteoporosis

Start: 2008-02-29Target: 32Updated: 2016-05-02

Phase 2

A Phase II Study Evaluating SB-751689 in Post-Menopausal Women With Osteoporosis.

TerminatedNCT00471237

GlaxoSmithKlineOsteoporosis

Start: 2007-05-14End: 2008-12-26Updated: 2017-11-07